Monoclonal antibodies are novel therapeutic agents ... difficulties since duration and severity of disease, concomitant medications and illnesses, dates of studies performed, inclusion/exclusion ...

The potential of monoclonal antibodies (mAbs) as therapies is indisputable. The current mAbs market is expected to be around ~USD 150 billion. In 2021, five out of the top 10 selling drugs were ...

MSD’s monoclonal antibody, indicated for 15 types of cancer, smashed industry records with sales of $27.3 billion in 2024, ...

Now CVS is deploying that same approach to the much more profitable business of blockbuster prescription drugs. The move already ... 85% lower than the Humira list price, the company said.

With a growing list of regulatory approvals sparking sustained interest in producing monoclonal antibodies, Eppendorf has been supporting researchers who are working with both bacterial and ...

A BLA has been filed for bentracimab and, if approved, has the potential to be the first therapy to reverse the effects of ...

With over 80 publications, Mohta has expertise in the use of biological drugs for both cutaneous and systemic disorders. View Full Profile. Learn about our Editorial Policies. Scientists create ...

The Food and Drug Administration has approved more than 100 monoclonal antibodies to treat a range of diseases. Other antibodies are used by physicians to diagnose conditions or by scientists to ...

An antibody discovery platform revealed more than 60 monoclonal antibodies specific to patients with alpha-gal syndrome, ...